Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Dr. Syed Hussain from Trinity Health of New England has the latest health news on bird flu, and studies on cancer rates in ...

A study has revealed that a delicious hot drink could be the secret to shedding pounds and reducing health risks, all for as ...

Colon cancer remains one of the most prevalent yet often undetected forms of cancer, developing silently in the large ...

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...